Prehabilitation in Gynaecological Cancer Patients (PHOCUS)
Ovarian Cancer, Ovarian Cancer Stage III, Ovarian Cancer Stage IV
About this trial
This is an interventional supportive care trial for Ovarian Cancer focused on measuring Prehabilitation, Epitelial ovarian cancer, Functional capacity, Quality of life, Multimodal prehabilitation, Frailty, Endometrial cancer
Eligibility Criteria
Inclusion criteria
Two groups of patients will be eligible for the trial:
i) Epithelial ovarian cancer patients referred for NACT: a) FIGO stage III or IV disease; b) Patient is not a candidate for primary debulking surgery; c) Patient is a suitable candidate for standard of care combined chemotherapy; d) Patient is a candidate for interval.debulking surgery
ii) Stage I or II endometrial cancer patients classifying as frail according to the validated modified Frailty Index: a) FIGO stage I or II; b) Patient is classified as frail; c) Patient is suitable candidate for hormonal therapy.
Exclusion criteria
- Second malignant tumour (under the treatment)
- Patient is not suitable for any surgery delay
- Patient is not physically able to meet the prehabilitation intervention plan or is unable to walk
Sites / Locations
- Gynecologic Oncology Center in PragueRecruiting
Arms of the Study
Arm 1
Arm 2
No Intervention
Experimental
A
B
Patients will be provided with a basic information and standard of care support.
Active prehabilitation will be provided, composed of i) three physical activity-related interventions provided by a physical and rehabilitation medicine (PRM) specialist; iii) three 30 min consultations regarding nutritional status with physician or nutrition specialist; ii) three sessions with psychologist.